Monoclonal antibody SM-3
Alternative Names: SM-3Latest Information Update: 25 Jun 2008
At a glance
- Originator Imperial Cancer Research Technology
- Class Antineoplastics; Monoclonal antibodies
- Mechanism of Action Antibody-dependent cell cytotoxicity; Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer; Polycythaemia vera
Most Recent Events
- 19 Sep 2001 No-Development-Reported for Polycythaemia vera in United Kingdom (Unknown route)
- 14 Jul 1998 No-Development-Reported for Cancer in Germany (Unknown route)
- 14 Jul 1998 No-Development-Reported for Cancer in USA (Unknown route)